pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,028 catalysts · 3,603 8k filing · 1,346 grant · 1,000 device adverse event · 581 earnings · 550 approval · 430 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-03-01×clear all
type
  • 8k filing3,603
  • grant1,346
  • device adverse event1,000
  • earnings581
  • approval550
  • device 510k430
device pma
248
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 30, 2026

    50
    ›Mar 31, 2026device adverse event152d agoASTRATECH IMPL EV 3.6S 11MM OS — Injury event

    Failure to Osseointegrate

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoINTERSTIM — Injury event

    Insufficient Information

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoCROSSLINK ANCHOR PG GLENOID 52 — Injury event

    Loss of or Failure to Bond; Naturally Worn

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoNEOSS — Injury event

    Fracture

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoMENTOR MEMORYGEL BREAST IMPLANT — Injury event

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoFREESTYLE LIBRE 3 — Injury event

    Device Alarm System

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoFREESTYLE LIBRE 2 PLUS — Injury eventTANDEM DIABETES CARE INC

    Unable to Obtain Readings; Device Displays Incorrect Message

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoSOFRADIM MESH — Injury event

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoNAVITOR VISION — Injury event

    Difficult to Fold, Unfold or Collapse; Patient-Device Incompatibility

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoFREESTYLE LIBRE 2 PLUS — Injury eventTANDEM DIABETES CARE INC

    High Readings

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoFIXTURE OSSEOSPEED 4.5 - 11 MM — Injury event

    Fracture

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoGLIDEWELL HT IMPLANT Ø5.0 X 10 MM — Injury event

    Failure to Osseointegrate

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoIMPELLA — Death event

    Patient Device Interaction Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoASTRATECH IMPL EV 4.2S 9MM OS — Injury event

    Loss of Osseointegration

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoARTICULATION KIT SIZE 5/6 — Injury eventZIMMER BIOMET HOLDINGS, INC.

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoMENTOR MEMORYGEL BREAST IMPLANT — Injury event

    Material Rupture

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoULNAR-STEM-SZ5-115MM-RT — Injury eventZIMMER BIOMET HOLDINGS, INC.

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoMENTOR MEMORYGEL BREAST IMPLANT — Injury event

    Material Rupture

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoHUMERAL-SCREW-KIT — Injury eventZIMMER BIOMET HOLDINGS, INC.

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoANK C/X IMPL A9.5/D3.5/L9.5 — Injury event

    Loss of Osseointegration

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoNUCLEUS CI632 PROFILE PLUS WITH SLIM MODIOLAR ELECTRODE — Injury event

    Failure to Read Input Signal

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoNUCLEUS CI632 PROFILE PLUS WITH SLIM MODIOLAR ELECTRODE — Injury event

    Failure to Read Input Signal

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoGLOBAL AP HUMERAL STEM 14MM — Injury event

    Adverse Event Without Identified Device or Use Problem

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoOMNILINK ELITE — Injury event

    Difficult to Advance; Device Dislodged or Dislocated

    full page →fda device maude ↗
    ›Mar 31, 2026device adverse event152d agoOSSEOSPEED 4.5 - 13 MM — Injury event

    Fracture

    full page →fda device maude ↗
    ›Mar 31, 2026grant152d agoTULANE UNIVERSITY OF LOUISIANA — Development of a Rhesus Macaque Model of Persistent Oral HPV and HIV Co-infec...

    DE grant. $44,984. PI: Prasun K Datta

    full page →nih reporter ↗
    ›Mar 31, 2026grant152d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Determine the role of a monocarboxylate transporter in metabolism and intesti...

    DK grant. $34,272. PI: Rebekka Hannah Anderson

    full page →nih reporter ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

    Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2026approval151d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

    Sponsor: TARO PHARM INDS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2026approval151d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2026approval151d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2026approval151d agoBOSENTAN — FDA approvalJanssen-Cilag Holdings Inc (Inactive)

    Sponsor: SUN PHARM. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoVAFSEO (VADADUSTAT) — FDA approvalvadadustat

    Sponsor: AKEBIA. Form: TABLET. Route: ORAL

    full page →vadadustat →fda approvals ↗
    ›Apr 1, 2026approval151d agoKESIMPTA (OFATUMUMAB) — FDA approvalKESIMPTA

    Sponsor: NOVARTIS. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →KESIMPTA →fda approvals ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

    Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

    full page →adrenaline →fda approvals ↗
    ›Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →BREXPIPRAZOLE →fda approvals ↗
    ›Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →BREXPIPRAZOLE →fda approvals ↗
    ›Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →BREXPIPRAZOLE →fda approvals ↗
    ›Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →BREXPIPRAZOLE →fda approvals ↗
    ›Apr 1, 2026approval151d agoBREXPIPRAZOLE — FDA approvalBREXPIPRAZOLE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →BREXPIPRAZOLE →fda approvals ↗
    ›Apr 1, 2026approval151d agoFOUNDAYO (ORFORGLIPRON CALCIUM) — FDA approvalorforglipron calcium

    Sponsor: ELI LILLY AND CO. Form: TABLET. Route: ORAL

    full page →orforglipron calcium →fda approvals ↗
    ›Apr 1, 2026approval151d agoPROCHLORPERAZINE EDISYLATE — FDA approvalPROCHLORPERAZINE EDISYLATE

    Sponsor: SOMERSET THERAPS LLC. Form: INJECTABLE. Route: INJECTION

    full page →PROCHLORPERAZINE EDISYLATE →fda approvals ↗
    ›Apr 1, 2026recall151d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9259-08. — Reason: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 1, 2026recall151d agoMACLEODS PHARMA USA, INC recall (Cls II)Macleods Pharma USA Inc

    Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Princeton, NJ, Manufactured by: Macleods Pharmaceuticals Ltd., Sarigam, Valsad, Guajarat, INDIA NDC 33342-401-44 — Reason: Subpotent Drug — Status: Ongoing

    full page →fda recalls ↗
    ›Apr 1, 2026recall151d agoTeva Pharmaceuticals USA, Inc recall (Cls II)Terns Pharmaceuticals, Inc.

    Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial, Rx only, Manufactured in Greece BY: Pharmathen International S.A, Rodopi, 693 00 Greece, Manufactured For: TEVA Pharmaceuticals, Parsippany, NJ 07054, NDC 0480-9257-08. — Reason: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer. — Status: Ongoing

    full page →fda recalls ↗
    ← prev
    page 51 of 161
    next →
    $TNDM21.40+0.14%
    $ZBH87.97+0.93%
    $TNDM21.40+0.14%
    $ZBH87.97+0.93%
    $ZBH87.97+0.93%
    $AKBA1.2900-2.27%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $AMRX17.54-2.61%
    $NVS153.81-0.54%
    $AMRX17.54-2.61%
    $LLY1174.61-0.13%
    $TERN52.95-0.03%
    $TERN52.95-0.03%